Viji Pulikkel Chandran
Overview
Explore the profile of Viji Pulikkel Chandran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shenoy S, Rajan A, Rashid M, Chandran V, Poojari P, Kunhikatta V, et al.
PLoS Negl Trop Dis
. 2022 Jun;
16(6):e0010455.
PMID: 35771774
Background And Objective: Differentiating tropical infections are difficult due to its homogenous nature of clinical and laboratorial presentations among them. Sophisticated differential tests and prediction tools are better ways to...
12.
Dsa F, Fernandes E, Kesarkar S, Swaminathan L, Kunhikatta V, Rashid M, et al.
J Clin Pharm Ther
. 2022 Apr;
47(8):1103-1111.
PMID: 35403222
What Is Known And Objective: The effect of histamine-2 receptor antagonists (H2RAs) use causing inflammatory bowel diseases (IBD) has been reported in few isolated observational studies; however, pooled estimation of...
13.
Chandran V, Balakrishnan A, Rashid M, Pai Kulyadi G, Khan S, Devi E, et al.
PLoS One
. 2022 Mar;
17(3):e0265927.
PMID: 35324994
Objective: This review evaluates the effectiveness of smartphone applications in improving academic performance and clinical practice among healthcare professionals and students. Methods: This study followed the Preferred Reporting Items for...
14.
Shetty R, Basheer F, Poojari P, Thunga G, Chandran V, Acharya L
Diabetes Metab Syndr
. 2022 Feb;
16(3):102427.
PMID: 35217468
Background And Aim: The importance of glucagon-like peptide-1 (GLP-1) agonists is increasing because of its blood sugar controlling and weight loss properties. The data regarding safety of GLP-1 agonists are...
15.
Rashid M, Chandran V, Nair S, Muthu D, Pappuraj J, Jacob K, et al.
Curr Rev Clin Exp Pharmacol
. 2021 Aug;
17(3):192-204.
PMID: 34455951
Background: Treatment with N-Acetyl Cysteine (NAC) in rodenticide poisoning has not been well established due to mixed study results and insufficient evidence. This review aimed to summarize the clinical benefits...
16.
Rashid M, Khan S, Datta D, Thunga G, Chandran V, Balakrishnan A, et al.
Int J Clin Pract
. 2021 Jul;
75(11):e14645.
PMID: 34310805
Background: Evidence-based recommendations on the efficacy and safety of corticosteroids in acute respiratory distress syndrome (ARDS) remain a therapeutic challenge. Findings from several systematic reviews and meta-analyses are inconsistent. We...